TIDES ® 2012 Scientific Advisory Committee

Manufacturing Technology and Product Development

Kathryn L. Ackley, Ph.D., Vice President, Business Development and Project Management, Girindus America, Inc. Member of Solvay Group

Firoz Antia, Ph.D., CMC Team Director, Pharmaceutical Operations and Technology, Biogen Idec

Mimoun Ayoub, Ph.D., Vice President, Strategic Development, Peptisyntha, Member of The Solvay Group, Belgium

Neil H. Baine, Ph.D., Executive Director, Scinovo, Preclinical Development, GlaxoSmithKline Pharmaceuticals

Doug Brooks, Ph.D., Executive Director, Chemistry, Regado Biosciences

Mark Francis, MRSC, CChem, Csi, Director, Formulation Process and Analysis, UK, GlaxoSmithKline, United Kingdom

Matthieu Giraud, Ph.D., Director, Lonza Chemicals R&D Peptides, Lonza Ltd., Switzerland

Peter Hoffmann, Ph.D.

Christopher P. Holmes, Ph.D., Executive Director, Chemistry, Affymax, Inc.

Troels Koch, Ph.D., Vice President and CTO, Santaris Pharma A/S, Denmark

Rodney Lax, Ph.D., Senior Director, Business Development, PolyPeptide Group

Zhen Li, Ph.D., Associate Director, RNA Oligonucleotide Synthesis/DPC, Merck Research Laboratories

David Litzinger, Ph.D., Director, Pharmaceutical Sciences, Amylin Pharmaceuticals, Inc.

Derek Maclean, Director, Chemistry, Kai Pharmaceuticals

Bing Mao, Ph.D., Associate Director, Process Research, Merck & Co., Inc.

John P. Mayer, Ph.D., Senior Research Advisor, Eli Lilly and Co.

Paul McCormac, Ph.D., Senior Manager, Biomanufacturing Sciences Group, Pfizer Global Manufacturing

Paul Metz, Senior Director, Manufacturing Operations, Agilent Technologies, Inc.

Bruce H. Morimoto, Ph.D., Vice President, Drug Development, Allon Therapeutics Inc., Canada

Gary F. Musso, Ph.D., President, Musso and Associates LLC

Lubomir V. Nechev, Ph.D., Senior Director, Process Chemistry, Alnylam Pharmaceuticals, Inc.

Philip Ottiger, President & CEO, Bachem Americas, Inc.

Rodney Parsons, Ph.D., Director, Process R&D, Bristol-Myers Squibb

Christopher A. Rhodes, Ph.D., President, baywindbio

G. Susan Srivatsa, Ph.D., President, ElixinPharma

James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, Quark Pharmaceuticals, Inc.

David Tumelty, Ph.D., Associate Director, Chemistry, BioTherapeutics R&D, Pfizer Inc.

Fran Wincott, Ph.D., President, Wincott & Associates, LLC

Emma Wright, Ph.D., Senior Director, Process Development, Avecia

Oligonucleotide Therapeutics Discovery

David Brown, Ph.D., Director of Research, Mirna Therapeutics, Inc.

Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, Quark Pharmaceuticals

Troels Koch, Ph.D., Vice President, Research and CTO, Santaris Pharma A/S, Denmark

Satya Kuchimanchi, Ph.D., Associate Director, RNAi Lead Development, Alnylam Pharmaceuticals, Inc.

Dmitry Samarsky, Ph.D., Executive Vice President, Technology Development, Guangzhou RiboBio Co. Ltd, China

Peptide Discovery and Development

Hanjo Hennemann, Ph.D., Executive Director and Head of R&D, Nexigen GmbH, Germany

Derek Maclean, Ph.D., Executive Director, Chemistry, KAI Pharmaceuticals

Tomi K. Sawyer, Ph.D., Chief Scientific Officer and Senior Vice President, Aileron Therapeutics Inc.

Peter Timmerman, Ph.D., Chief Technology Officer, Pepscan Therapeutics B.V., The Netherlands

David Tumelty, Ph.D., Associate Director Chemistry, BioTherapeutics R&D, CovX, Pfizer

Thomas Vorherr, Ph.D., Director, Peptide Discovery, Novartis Institutes for BioMedical Research, Switzerland

Paul Watt, Ph.D., CEO, Phylogica, Ltd, Australia

Nucleic Acids Technologies for Molecular Diagnostics

Thomas Battersby, Ph.D., Senior Manager, Siemens Healthcare Diagnostics

Michael Christopherson, Ph.D., Group Leader, Oligonucleotide Manufacturing, Roche Molecular Systems

B. Melina Cimler, Ph.D., Vice President, Quality and Regulatory, Illumina, Inc.

Dick Keys, Ph.D., President, Advanced Biotectonics